Boehringer Ingelheim GmbH

Cognitive Impairment in Schizophrenia Places Substantial Burden on Caregivers

New research on schizophrenia conducted by Boehringer Ingelheim International GmbH has identified a significant burden experienced by caregivers of patients with the condition. The study, which analyzed interviews from a Schizophrenia Cognition Rating Scale (SCoRS) confirmation study, found that primary and secondary caregivers reported substantial difficulties in assisting patients with